There is urgent need for new therapeutic strategies to fight the global threat of antibiotic resistance. The focus of this Perspective is on chemical agents that target the most common mechanisms of antibiotic resistance such as enzymatic inactivation of antibiotics, changes in cell permeability, and induction/activation of efflux pumps. Here we assess the current landscape and challenges in the treatment of antibiotic resistance mechanisms at both bacterial cell and community levels. We also discuss the potential clinical application of chemical inhibitors of antibiotic resistance mechanisms as add-on treatments for serious drug-resistant infections. Enzymatic inhibitors, such as the derivatives of the β-lactamase inhibitor avibactam, are closer to the clinic than other molecules. For example, MK-7655, in combination with imipenem, is in clinical development for the treatment of infections caused by carbapenem-resistant Enterobacteriaceae and Pseudomonas aeruginosa, which are difficult to treat. In addition, other molecules targeting multidrug-resistance mechanisms, such as efflux pumps, are under development and hold promise for the treatment of multidrug resistant infections.

Schillaci, D., Spano', V., Parrino, B., Carbone, A., Montalbano, A., Barraja, P., et al. (2017). Pharmaceutical Approaches to Target Antibiotic Resistance Mechanisms. JOURNAL OF MEDICINAL CHEMISTRY, 60(20), 8268-8297 [10.1021/acs.jmedchem.7b00215].

Pharmaceutical Approaches to Target Antibiotic Resistance Mechanisms

Schillaci, Domenico;Spanò, Virginia;Parrino, Barbara;Carbone, Anna;Montalbano, Alessandra;Barraja, Paola;Diana, Patrizia;Cirrincione, Girolamo;Cascioferro, Stella
2017-10-26

Abstract

There is urgent need for new therapeutic strategies to fight the global threat of antibiotic resistance. The focus of this Perspective is on chemical agents that target the most common mechanisms of antibiotic resistance such as enzymatic inactivation of antibiotics, changes in cell permeability, and induction/activation of efflux pumps. Here we assess the current landscape and challenges in the treatment of antibiotic resistance mechanisms at both bacterial cell and community levels. We also discuss the potential clinical application of chemical inhibitors of antibiotic resistance mechanisms as add-on treatments for serious drug-resistant infections. Enzymatic inhibitors, such as the derivatives of the β-lactamase inhibitor avibactam, are closer to the clinic than other molecules. For example, MK-7655, in combination with imipenem, is in clinical development for the treatment of infections caused by carbapenem-resistant Enterobacteriaceae and Pseudomonas aeruginosa, which are difficult to treat. In addition, other molecules targeting multidrug-resistance mechanisms, such as efflux pumps, are under development and hold promise for the treatment of multidrug resistant infections.
Settore BIO/19 - Microbiologia Generale
Settore CHIM/08 - Chimica Farmaceutica
https://pubs.acs.org/doi/10.1021/acs.jmedchem.7b00215#
Schillaci, D., Spano', V., Parrino, B., Carbone, A., Montalbano, A., Barraja, P., et al. (2017). Pharmaceutical Approaches to Target Antibiotic Resistance Mechanisms. JOURNAL OF MEDICINAL CHEMISTRY, 60(20), 8268-8297 [10.1021/acs.jmedchem.7b00215].
File in questo prodotto:
File Dimensione Formato  
J. Med. Chem. 2017, 60, 8268-8297.pdf

non disponibili

Descrizione: Articolo principale
Tipologia: Versione Editoriale
Dimensione 4.03 MB
Formato Adobe PDF
4.03 MB Adobe PDF   Visualizza/Apri   Richiedi una copia

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: http://hdl.handle.net/10447/245661
Citazioni
  • ???jsp.display-item.citation.pmc??? 34
  • Scopus 96
  • ???jsp.display-item.citation.isi??? 94
social impact